10. November 2023 – In 2023, the Access Consortium established a working group for advance therapy medicinal products (ATMPs). The main goals of this group are to foster interdisciplinary (quality, non-clinical, clinical) scientific discussions on emerging therapeutic concepts and technologies and to encourage mutual exchange and harmonization on the regulatory assessment of ATMPS.

For more information, see here.